Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8759348
APP PUB NO 20100305065A1
SERIAL NO

12600470

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided the use of compounds of formula wherein R1, R2, R3 and E have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula (I) per se.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELPERBY THERAPEUTICS LIMITEDLONDON GREATER LONDON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beswick, Mandy Christine Barcelona, GB 6 63
Coates, Anthony London, GB 18 53
Cramp, Susan Mary Harlow, GB 23 209
Dyke, Hazel Joan Harlow, GB 72 840
Hu, Yanmin London, GB 30 90
Pallin, Thomas David London, GB 25 232

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00